Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department

Background: *Soluble urokinase-type plasminogen activator receptor (suPAR) is a new biomarker, which is increased in conditions associated with inflammatory immune cell activation. In low resource, densely populated countries, there is a need for a quick test for triage and prognosticating in the em...

Full description

Bibliographic Details
Main Authors: Pratyush Kumar, Atul Kakar, Atul Gogia, NIamatullah Waziri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=12;spage=3871;epage=3875;aulast=Kumar
id doaj-64e57dd3ee984512861b30b4ba27467f
record_format Article
spelling doaj-64e57dd3ee984512861b30b4ba27467f2020-11-25T00:44:09ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632019-01-018123871387510.4103/jfmpc.jfmpc_116_19Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency departmentPratyush KumarAtul KakarAtul GogiaNIamatullah WaziriBackground: *Soluble urokinase-type plasminogen activator receptor (suPAR) is a new biomarker, which is increased in conditions associated with inflammatory immune cell activation. In low resource, densely populated countries, there is a need for a quick test for triage and prognosticating in the emergency department. Materials and Methods: *A pilot, observational study was conducted wherein all consenting adult patients (>18 years) presented to casualty with acute medical illnesses were included. Detailed clinical history, examination, and suPAR quick tests were done and patients were categorized into five groups based on the emergency severity index (ESI) triage algorithm. Patients with suPAR level more than 5.5 ng/mL were advised hospitalization and those below were advised follow-up. All patients were followed-up after 3 days. Results: Total 190 patients (20–80 years), 80 males and 110 females participated. ESI triage 1, 2, and 3 had suPAR levels > 5.5 ng/mL and ESI triage 4 and 5 had suPAR level of <5.5 ng/mL. In ESI-1, 29 patients were admitted in ICU and 16 left against medical advice (LAMA) and on follow-up mortality was 96% (P = <0.05). In ESI-2, all patients were admitted in high dependency units and on follow-up they still needed hospitalization. In ESI-3, 22 patients admitted in ward and 24 went LAMA, on follow-up all improved except LAMA patients who required hospitalization (P – <0.05). Patients in ESI-4 and 5 did not require admission (P = <0.001).Conclusion: *suPAR can reliably be used in the emergency department to prognosticate and triage.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=12;spage=3871;epage=3875;aulast=Kumaremergencyprimary caresupartriage
collection DOAJ
language English
format Article
sources DOAJ
author Pratyush Kumar
Atul Kakar
Atul Gogia
NIamatullah Waziri
spellingShingle Pratyush Kumar
Atul Kakar
Atul Gogia
NIamatullah Waziri
Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
Journal of Family Medicine and Primary Care
emergency
primary care
supar
triage
author_facet Pratyush Kumar
Atul Kakar
Atul Gogia
NIamatullah Waziri
author_sort Pratyush Kumar
title Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
title_short Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
title_full Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
title_fullStr Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
title_full_unstemmed Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
title_sort evaluation of soluble urokinase-type plasminogen activator receptor (supar) quick test for triage in the emergency department
publisher Wolters Kluwer Medknow Publications
series Journal of Family Medicine and Primary Care
issn 2249-4863
publishDate 2019-01-01
description Background: *Soluble urokinase-type plasminogen activator receptor (suPAR) is a new biomarker, which is increased in conditions associated with inflammatory immune cell activation. In low resource, densely populated countries, there is a need for a quick test for triage and prognosticating in the emergency department. Materials and Methods: *A pilot, observational study was conducted wherein all consenting adult patients (>18 years) presented to casualty with acute medical illnesses were included. Detailed clinical history, examination, and suPAR quick tests were done and patients were categorized into five groups based on the emergency severity index (ESI) triage algorithm. Patients with suPAR level more than 5.5 ng/mL were advised hospitalization and those below were advised follow-up. All patients were followed-up after 3 days. Results: Total 190 patients (20–80 years), 80 males and 110 females participated. ESI triage 1, 2, and 3 had suPAR levels > 5.5 ng/mL and ESI triage 4 and 5 had suPAR level of <5.5 ng/mL. In ESI-1, 29 patients were admitted in ICU and 16 left against medical advice (LAMA) and on follow-up mortality was 96% (P = <0.05). In ESI-2, all patients were admitted in high dependency units and on follow-up they still needed hospitalization. In ESI-3, 22 patients admitted in ward and 24 went LAMA, on follow-up all improved except LAMA patients who required hospitalization (P – <0.05). Patients in ESI-4 and 5 did not require admission (P = <0.001).Conclusion: *suPAR can reliably be used in the emergency department to prognosticate and triage.
topic emergency
primary care
supar
triage
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=12;spage=3871;epage=3875;aulast=Kumar
work_keys_str_mv AT pratyushkumar evaluationofsolubleurokinasetypeplasminogenactivatorreceptorsuparquicktestfortriageintheemergencydepartment
AT atulkakar evaluationofsolubleurokinasetypeplasminogenactivatorreceptorsuparquicktestfortriageintheemergencydepartment
AT atulgogia evaluationofsolubleurokinasetypeplasminogenactivatorreceptorsuparquicktestfortriageintheemergencydepartment
AT niamatullahwaziri evaluationofsolubleurokinasetypeplasminogenactivatorreceptorsuparquicktestfortriageintheemergencydepartment
_version_ 1725276239021735936